274 related articles for article (PubMed ID: 23485384)
1. Multidrug resistance in new tuberculosis patients: burden and implications.
Royce S; Falzon D; van Weezenbeek C; Dara M; Hyder K; Hopewell P; Richardson MD; Zignol M
Int J Tuberc Lung Dis; 2013 Apr; 17(4):511-3. PubMed ID: 23485384
[TBL] [Abstract][Full Text] [Related]
2. [Drug resistant tuberculosis].
Zwolska Z; Augustynowicz-Kopeć E
Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
Judge D; Krause V
Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
[TBL] [Abstract][Full Text] [Related]
5. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistant tuberculosis: trends and control.
Prasad R; Gupta N; Singh M
Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
Caminero JA
Int J Tuberc Lung Dis; 2010 Apr; 14(4):382-90. PubMed ID: 20202293
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
Ahmad S; Mokaddas E
Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
[TBL] [Abstract][Full Text] [Related]
9. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
[TBL] [Abstract][Full Text] [Related]
10. Successful management of multidrug-resistant tuberculosis under programme conditions in the Dominican Republic.
Rodriguez M; Monedero I; Caminero JA; Encarnación M; Dominguez Y; Acosta I; Muñoz E; Camilo E; Martinez-Selmo S; de los Santos S; del Granado M; Casals M; Cayla J; Marcelino B
Int J Tuberc Lung Dis; 2013 Apr; 17(4):520-5. PubMed ID: 23485386
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA
Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
[TBL] [Abstract][Full Text] [Related]
12. Current issues in the management of tuberculosis in Europe.
Zellweger JP
Panminerva Med; 2013 Jun; 55(2):145-55. PubMed ID: 23676956
[TBL] [Abstract][Full Text] [Related]
13. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
14. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
[TBL] [Abstract][Full Text] [Related]
15. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
16. [Multidrug resistant tuberculosis -- its extent, hazard and possible solutions].
Zellweger JP
Rev Mal Respir; 2011 Oct; 28(8):1025-33. PubMed ID: 22099408
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis.
Bojorquez-Chapela I; Bäcker CE; Orejel I; López A; Díaz-Quiñonez A; Hernández-Serrato MI; Balandrano S; Romero M; Téllez-Rojo Solís MM; Castellanos M; Alpuche C; Hernández-Ávila M; López-Gatell H
Int J Tuberc Lung Dis; 2013 Apr; 17(4):514-9. PubMed ID: 23485385
[TBL] [Abstract][Full Text] [Related]
18. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
19. The management of tuberculosis: epidemiology, resistance and monitoring.
Bang D
Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374
[TBL] [Abstract][Full Text] [Related]
20. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
